ABP
EW icon

Arthur B. Page’s Edwards Lifesciences EW Stock Holding History

Arthur B. Page’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,881
Closed -$823K – 42
2023
Q3 		$823K Sell
11,881
-860
-7% -$69.1K 0.85% 34
2023
Q2 		$1.2M Sell
12,741
-1,137
-8% -$98.8K 1.14% 31
2023
Q1 		$1.15M Buy
13,878
+1,600
+13% +$126K 1.08% 31
2022
Q4 		$916K Sell
12,278
-615
-5% -$47.4K 0.9% 33
2022
Q3 		$1.06M Buy
12,893
+390
+3% +$37.5K 1.11% 32
2022
Q2 		$1.19M Sell
12,503
-28
-0.2% -$2.9K 1.13% 34
2022
Q1 		$1.48M Buy
12,531
+1,400
+13% +$157K 1.15% 34
2021
Q4 		$1.44M Buy
11,131
+7,423
+200% +$866K 0.99% 36
2021
Q3 		$420K Buy
+3,708
New +$423K 0.31% 47

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Arthur B. Page's EW Position: Q4 2023 in Review

Arthur B. Page sold out of Edwards Lifesciences (EW) in Q4 2023, closing a stake of 11,881 shares — an estimated $823K sold.

Arthur B. Page first reported a position in EW in Q3 2021 and held it in 9 quarters. The position peaked at $1.48M in Q1 2022. 1,245 funds tracked by Wall St. Rank hold EW as of Q4 2023.

  • Arthur B. Page reported no remaining Edwards Lifesciences position as of Q4 2023 after selling out during the quarter.
  • Arthur B. Page sold 11,881 Edwards Lifesciences shares in Q4 2023, an estimated $823K.
  • Arthur B. Page first reported a position in Edwards Lifesciences in Q3 2021 and held it in 9 quarters.
  • Arthur B. Page's Edwards Lifesciences position peaked at $1.48M in Q1 2022.
  • 1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2023.

Based on Arthur B. Page's 13F filing for Q4 2023, filed 14 Feb 2024.